Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
- 14 May 2012
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (22), 8511-8516
- https://doi.org/10.1073/pnas.1118370109
Abstract
Human malaria infection begins with a one-time asymptomatic liver stage followed by a cyclic symptomatic blood stage. All high-throughput malaria drug discovery efforts have focused on the cyclic blood stage, which has limited potential for the prophylaxis, transmission blocking, and eradication efforts that will be needed in the future. To address these unmet needs, a high-throughput phenotypic liver-stage Plasmodium parasite screen was developed to systematically identify molecules with liver-stage efficacy. The screen recapitulates liver-stage infection by isolating luciferase-expressing Plasmodium berghei parasites directly from the salivary glands of infected mosquitoes, adding them to confluent human liver cells in 384-well plates, and measuring luciferase activity after a suitable incubation period. Screening 5,375 known bioactive compounds identified 37 liver-stage malaria inhibitors with diverse modes of action, as shown by inhibition time course experiments. Further analysis of the hits in the Food and Drug Administration-approved drug subset revealed compounds that seem to act specifically on the liver stage of infection, suggesting that this phase of the parasite's life cycle presents a promising area for new drug discovery. Notably, many active compounds in this screen have molecular structures and putative targets distinctly different from those of known antimalarial agents.Keywords
This publication has 42 references indexed in Scilit:
- Characterization of Plasmodium Liver Stage Inhibition by HalofuginoneChemMedChem, 2012
- A toolbox to study liver stage malariaTrends in Parasitology, 2011
- The Next Opportunity in Anti-Malaria Drug Discovery: The Liver StagePLoS Pathogens, 2011
- Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular TargetsScience, 2011
- Organelle segregation into Plasmodium liver stage merozoitesCellular Microbiology, 2011
- Thousands of chemical starting points for antimalarial lead identificationNature, 2010
- Transcriptional Analysis of the Pre-Erythrocytic Stages of the Rodent Malaria Parasite, Plasmodium yoeliiPLOS ONE, 2010
- A Systems-Based Analysis of Plasmodium vivax Lifecycle Transcription from Human to MosquitoPLoS Neglected Tropical Diseases, 2010
- A pre-emptive strike against malaria's stealthy hepatic formsNature Reviews Drug Discovery, 2009
- History of Methysergide in MigraineCephalalgia, 2008